Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Social Capital Suvretta Holdings Corporation III (DNAC)
Social Capital Suvretta Holdings Corporation III (DNAC) Actualités

DNAC

Social Capital Suvretta ... (DNAC)

Social Capital Suvretta Holdings Corporation III

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:DNAC

Date	Heure	Source	Titre	Symbole	Société
16/06/2023	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
26/05/2023	14h01	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
26/05/2023	13h33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
11/05/2023	22h11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
21/04/2023	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
17/04/2023	23h02	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
04/04/2023	22h47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
29/03/2023	12h06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
28/03/2023	22h47	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
14/02/2023	18h24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
06/01/2023	22h59	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
26/08/2022	22h07	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
12/08/2022	13h16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
09/08/2022	12h10	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
22/07/2022	22h40	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
22/07/2022	12h01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
20/07/2022	22h32	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
12/07/2022	14h00	GlobeNewswire Inc.	Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
09/07/2022	01h36	Business Wire	Social Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of Shareholders	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
06/07/2022	14h46	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
23/06/2022	14h00	GlobeNewswire Inc.	ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney Disease	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
15/06/2022	14h00	GlobeNewswire Inc.	ProKidney Announces Manufacturing Efficiency Initiatives and Supply Chain Streamlining Expected to Reduce REACT™ Manufacturing Costs	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
10/06/2022	22h55	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (definitive) (defm14a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
07/06/2022	14h00	GlobeNewswire Inc.	Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 Update	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
20/05/2022	15h00	GlobeNewswire Inc.	ProKidney to present at upcoming investor conferences	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
06/05/2022	22h48	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
03/05/2022	14h00	GlobeNewswire Inc.	ProKidney highlights key registrational program elements supporting advancement of REACT®	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
18/04/2022	15h30	GlobeNewswire Inc.	ProKidney and Social Capital Suvretta Holdings Corp. III (“SCS”) to Host Analyst and Investor Day on April 28, 2022	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
12/04/2022	14h00	GlobeNewswire Inc.	ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III
14/02/2022	23h14	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:DNAC	Social Capital Suvretta Holdings Corporation III

Showing the most relevant articles for your search:NASDAQ:DNAC

Cie de SaintGobain

JP Morgan Chase

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales